Internal Medicine NewsHuge trial casts doubt on bisphosphonates for breast cancerJuly 6, 2021Breast CancerOncology
Internal Medicine NewsCDC notes sharp declines in breast and cervical cancer screeningJuly 2, 2021Women's HealthBusiness of MedicinePreventive CareOncologyHematologyBreast Cancer
Internal Medicine NewsNo increase in breast cancer risk with fertility treatmentsJune 29, 2021Breast CancerOncology
Internal Medicine NewsRapid update to ASCO breast cancer guidelines after OlympiA dataJune 22, 2021Breast CancerOncology
Internal Medicine NewsDCIS: Biosignature helps guide postlumpectomy decisionsJune 22, 2021Breast CancerOncology
Internal Medicine NewsKey strategies for managing breast cancer brain metastasesJune 17, 2021Breast Cancer
Internal Medicine NewsFreezing breast cancer to death avoids surgery: Why not further along?June 16, 2021Breast Cancer
Internal Medicine NewsPromising HER2+/HR– breast cancer survival with de-escalated therapyJune 15, 2021Breast CancerOncology
Internal Medicine NewsCONCERT: Better QoL but not survival with cabazitaxel in metastatic HER2– breast cancerJune 7, 2021Breast Cancer
Internal Medicine NewsGenomic signature predicts safety of omitting RT in early breast cancerJune 7, 2021Breast CancerOncology
Internal Medicine NewsACE inhibitor prevents trastuzumab-associated LVEF decline after anthracyclines in BC treatmentJune 7, 2021Breast CancerPreventive Care
Internal Medicine NewsPregnancy effect on chemotherapy does not affect maternal breast cancer outcomesJune 7, 2021Breast CancerOncologyWomen's Health
Internal Medicine News'Exciting': Olaparib benefit also in early BRCA+ breast cancer June 4, 2021Breast Cancer
Internal Medicine NewsIL-6 levels predict distant breast cancer recurrenceJune 4, 2021Breast CancerOncologyWomen's Health
